Juan Du, Xiang Kong, Hui-zi Sha, Xinyuan Bai, Yaru Liu, Yiying Gao, Weiwei Kong, Baorui Liu. "Integrated NAL-IRI/5-FU/LV, benmelstobart, anlotinib with or without immunoradiotherapy for second-line metastatic pancreatic cancer: A phase II dual-cohort study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e16374